MRNA
Price
$30.49
Change
+$0.21 (+0.69%)
Updated
Jul 3 closing price
Capitalization
11.79B
25 days until earnings call
RXRX
Price
$5.27
Change
+$0.06 (+1.15%)
Updated
Jul 3 closing price
Capitalization
2.14B
37 days until earnings call
Interact to see
Advertisement

MRNA vs RXRX

Header iconMRNA vs RXRX Comparison
Open Charts MRNA vs RXRXBanner chart's image
Moderna
Price$30.49
Change+$0.21 (+0.69%)
Volume$6.97M
Capitalization11.79B
Recursion Pharmaceuticals
Price$5.27
Change+$0.06 (+1.15%)
Volume$16.58M
Capitalization2.14B
MRNA vs RXRX Comparison Chart in %
Loading...
MRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MRNA vs. RXRX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRNA is a Hold and RXRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (MRNA: $30.49 vs. RXRX: $5.27)
Brand notoriety: MRNA: Notable vs. RXRX: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MRNA: 60% vs. RXRX: 65%
Market capitalization -- MRNA: $11.79B vs. RXRX: $2.14B
MRNA [@Biotechnology] is valued at $11.79B. RXRX’s [@Biotechnology] market capitalization is $2.14B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRNA’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • MRNA’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, MRNA is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRNA’s TA Score shows that 5 TA indicator(s) are bullish while RXRX’s TA Score has 5 bullish TA indicator(s).

  • MRNA’s TA Score: 5 bullish, 4 bearish.
  • RXRX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than MRNA.

Price Growth

MRNA (@Biotechnology) experienced а +10.71% price change this week, while RXRX (@Biotechnology) price change was -2.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

MRNA is expected to report earnings on Oct 30, 2025.

RXRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRNA($11.8B) has a higher market cap than RXRX($2.14B). RXRX YTD gains are higher at: -22.041 vs. MRNA (-26.671). RXRX has higher annual earnings (EBITDA): -524.77M vs. MRNA (-3.2B). MRNA has more cash in the bank: 5.98B vs. RXRX (500M). RXRX has less debt than MRNA: RXRX (92.9M) vs MRNA (745M). MRNA has higher revenues than RXRX: MRNA (3.14B) vs RXRX (59.8M).
MRNARXRXMRNA / RXRX
Capitalization11.8B2.14B551%
EBITDA-3.2B-524.77M609%
Gain YTD-26.671-22.041121%
P/E RatioN/AN/A-
Revenue3.14B59.8M5,249%
Total Cash5.98B500M1,195%
Total Debt745M92.9M802%
FUNDAMENTALS RATINGS
MRNA: Fundamental Ratings
MRNA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MRNARXRX
RSI
ODDS (%)
Bearish Trend 4 days ago
72%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
78%
Momentum
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bullish Trend 4 days ago
73%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 19 days ago
85%
Bearish Trend 14 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
FOREX / NAMEPrice $Chg $Chg %
AUDNZD1.080.00
+0.08%
Australian Dollar - New Zealand Dollar
GBPCAD1.850.00
+0.02%
United Kingdom Pound - Canadian Dollar
CNYCAD0.19N/A
N/A
China Yuan - Canadian Dollar
USNZ37.57N/A
N/A
Xtrackers Net Zero Pwy Par Alg US Eq ETF
SUSB25.04-0.04
-0.16%
iShares ESG 1-5 Year USD Corp Bd ETF

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
+1.15%
CRSP - RXRX
72%
Closely correlated
+0.97%
BEAM - RXRX
64%
Loosely correlated
+0.65%
ABSI - RXRX
63%
Loosely correlated
+2.97%
ABCL - RXRX
61%
Loosely correlated
+1.33%
PRME - RXRX
58%
Loosely correlated
+1.30%
More